SCHEMBL3459368

SCHEMBL3459368

NC(N)CCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27679012 0.97
SCHEMBL7419522 0.81
SCHEMBL12898291 0.80 HIF1A (0.39)
SCHEMBL14601135 0.80 HIF1A (0.39)
SCHEMBL7408784 0.79
SCHEMBL690898 0.77 TSHR (0.46)
SCHEMBL8487319 0.77 TSHR (0.46)
SCHEMBL16306519 0.75
SCHEMBL2637832 0.75
SCHEMBL13368624 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105542166-A Selective laser sintered polyimide powder and preparation method thereof UNIV JIANGHAN 2016-05-04 CN claimed
CN-102766260-A Method for preparing polyimide in supercritical carbon dioxide HANGZHOU SURMOUNT SCIENCE & TECHNOLOGY CO LTD 2012-11-07 CN claimed
CN-101230136-B Polyimide microparticle and preparation method thereof TORAY FIBER RES INST CN CO LTD 2011-03-16 CN claimed
CN-101230136-A Polyimide microparticle and preparation method thereof TORAY FIBER RES INST CN CO LTD (CN) 2008-07-30 CN claimed
EP-1232183-A2 PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY ABBOTT LABORATORIES (US) 2002-08-21 EP claimed
WO-2001038347-A2 PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY ABBOTT LABORATORIES (US) 2001-05-31 WO claimed
CN-1085563-A New peptide and preparation thereof and application BASF AG (DE) 1994-04-20 CN claimed
CN-1056105-A The peptide that bradykinin-antagonistic action is arranged HOECHST AG (DE) 1991-11-13 CN claimed
WO-2022073469-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2022-04-14 WO disclosed
CN-110845579-A Polymyxin E component and photochemical product thereof and liquid chromatography-mass spectrometry analysis method 上海市食品药品检验所 2020-02-28 CN disclosed
CN-107207569-A Polymyxin derivatives and uses thereof 北方抗生素有限公司 2017-09-26 CN disclosed
CN-103524373-B Polyamines aryl buserelin chemical families, and cosmetics or cosmetics for skin application 爱西美有限公司 2016-12-28 CN disclosed
CN-105542166-A Selective laser sintered polyimide powder and preparation method thereof UNIV JIANGHAN 2016-05-04 CN disclosed
CN-104994862-A TOPICAL FORMULATIONS FOR INCREASING THE DERMAL CONCENTRATION OF HYALURONIC ACID PREC DERMATOLOGY INC 2015-10-21 CN disclosed
WO-1999017792-A1 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS BASF AKTIENGESELLSCHAFT (DE) 1999-04-15 WO disclosed
EP-0744619-B1 Ascorbate resistant detection of hydrogen peroxide BAYER AG (US) 1998-07-29 EP disclosed
EP-0744619-A1 Ascorbate resistant detection of hydrogen peroxide Bayer Corporation (US) 1996-11-27 EP disclosed
WO-1995002610-A1 ANALOGS OF PARATHYROID HORMONE AND PARATHYROID HORMONE RELATED PEPTIDE: SYNTHESIS AND USE FOR THE TREATMENT OF OSTEOPOROSIS SYNTEX (U.S.A.) INC. (US) 1995-01-26 WO disclosed
EP-0504663-A1 Peroxidase indicator system for basic media Bayer Corporation (US) 1992-09-23 EP disclosed
CN-1056105-A The peptide that bradykinin-antagonistic action is arranged HOECHST AG (DE) 1991-11-13 CN disclosed